Characteristic | Value |
---|---|
Neoadjuvant chemotherapy | Â |
 platinum |  |
  cisplatin | 67(82%) |
  carboplatin | 15(18%) |
 second agent |  |
  gemcitabine | 45(55%) |
  paclitaxel | 29(35%) |
  pemetrexed | 8(10%) |
Treatment cycles | Â |
  2 | 77(94%) |
  3 | 3(4%) |
  >3 | 2(2%) |
Type of resection | Â |
  pneumonectomy | 16(20%) |
  lobectomy | 52(63%) |
  bilobectomy | 8(10%) |
  wedge resections | 2(2%) |
  exploration | 4(5%) |
Completeness of resection | Â |
  R0 | 76(93%) |
  R1 | 1(1%) |
  R2 | 5(6%) |
Cell type after operation | Â |
 squamous | 51(62%) |
 adenocarcinoma | 29(35%) |
 large cell | 2(3%) |